MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Transcranial magnetic stimulation study in primary dystonia of presumed genetic etiology

    D. Dhar, A. Bhattacharya, N. Kamble, V. Holla, R. Yadav, B. Muthusamy, P. Pal (Bengaluru, India)

    Objective: To study the neurophysiological parameters in primary dystonia of presumed genetic etiology using transcranial magnetic stimulation (TMS) and correlate with their genotype. Background: The…
  • 2023 International Congress

    Pathological findings in a case of DJ-1 early onset Parkinson’s disease

    M. Schoenberg, D. Narendra, L. Kenyon, TW. Liang (Philadelphia, USA)

    Objective: To report the postmortem findings in a case of early onset genetically confirmed DJ-1 (PARK7) PD. Background: As a very rare cause (1-2%) of…
  • 2023 International Congress

    Emerging treatments targeting DNA and RNA in Huntington’s disease: a review of future perspectives and current challenges

    G. Lima, F. Sarmento, I. Camargo, R. Saba, S. Silva, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To review the progress made towards the development of a huntingtin (HTT) lowering strategy based on RNA and DNA and also to assess the…
  • 2023 International Congress

    Fragile X Related Tremor in FMR1 Premutation Women without FXTAS

    D. Hall, T. Svymbersky, J. O'Keefe, B. Ouyang, E. Berry-Kravis (Chicago, USA)

    Objective: To determine whether there is a FMR1 premutation associated tremor in women who do not meet criteria for Fragile X-associated tremor ataxia syndrome (FXTAS)…
  • 2023 International Congress

    Sub-cellular alterations in MPTP-induced in-vivo and in-vitro systems and Non-MPTP human Parkinsonian skin biopsies: Verifying the sequelae of differential toxicity

    P. Alladi, B. Bhaduri, S. Rashmi, I. Datta, P. Pal, D. Srinivas, R. Yadav (Bangalore, India)

    Objective: To evaluate the possible temporal hierarchy of sub-cellular organellar degeneration in experimental models of Parkinson’s disease (PD), using MPTP/MPP+ Background: Higher prevalence of PD in…
  • 2023 International Congress

    Evaluation of blood heavy metal concentrations in patients with essential tremor

    I. Korucu, A. Aksoy Gündoğdu, N. Bahtiyar (Tekirdag, Turkey)

    Objective: In this study, we aimed to investigate the relationship between tremor characteristics, neuropsychiatric status and blood heavy metal levels of essential tremor (ET) patients.…
  • 2023 International Congress

    Stability of basal ganglia beta band power distribution during continuous deep brain stimulation in Parkinson’s disease: analysis of sub-cohort from the ADAPT-PD trial

    L. Hammer, E. Yilmaz, S. Little, H. Zahed, M. Volz, S. Ravi, S. Wang, P. Starr, J. Ostrem (San Francisco, USA)

    Objective: To assess the stability of the daily distribution of peak subthalamic nucleus (STN) and globus pallidus internus (GPi) beta band power during continuous deep…
  • 2023 International Congress

    Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems

    M. de Neeling, M. Stam, B. van Wijk, J. Anso, R. Raike, P. Schuurman, R. de Bie, A. Buijink, M. Beudel (Amsterdam, Netherlands)

    Objective: To study the relationship between oscillatory beta activity in the subthalamic nucleus (STN) and the intake of dopaminergic medication in a group of Parkinson’s…
  • 2023 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

    I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…
  • 2023 International Congress

    Pharmacological Invivo and invitro potential of resveratrol in experimental rat models of Parkinson’s disease

    R. Kumar, A. Kanojia (Darbhanga, India)

    Objective: Aim of study was to elucidate the pharmacological Invivo and invitro effects and mechanisms of action ofRT in experimental models of PD. Background: The…
  • « Previous Page
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley